As of Feb 11
| +0.038 / +4.36%|
The 5 analysts offering 12-month price forecasts for TearLab Corp have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +339.56% increase from the last price of 0.91.
The current consensus among 5 polled investment analysts is to Buy stock in TearLab Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.